BioInvent International Stock

BioInvent International EBITDA per Share

The EBITDA per Share of BioInvent International (BINV.ST) as of Aug 12, 2026 is -5.34 SEK. In the previous year, EBITDA per Share was -6.88 SEK — a change of -22.46% (higher).

EBITDA per Share

-5.34SEK

YoY

-22.46%

Last updated:

EBITDA per Share of BioInvent International is 2026 -5.34 SEK. EBITDA per Share of BioInvent International was 2025 -6.88 SEK. It decreases by -22.46% higher compared to the previous year.
Access this data via the Eulerpool API
Get Free API Key

BioInvent International Stock analysis

What does BioInvent International do? BioInvent International AB is a Swedish biopharmaceutical company specializing in the discovery and development of therapeutic antibodies. It was founded in 1986 and is headquartered in Lund, Sweden. BioInvent conducts research and development activities in the fields of immuno-oncology, inflammatory diseases, and fibrosis. BioInvent International is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BioInvent International stock

EBITDA per Share of BioInvent International is -5.34 SEK in 2026.

EBITDA per Share of BioInvent International changed from -6.88 SEK to -5.34 SEK, representing a -22.46% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share BioInvent International since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — BioInvent International

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — BioInvent International